Zobrazeno 1 - 10
of 24
pro vyhledávání: '"Elena Vezali"'
Autor:
Ioannis S. Elefsiniotis, Christos Pavlidis, Elena Vezali, Theodoros Mariolis-Sapsakos, Sotirios Koutsounas, George Saroglou
Publikováno v:
Gastroenterology Research and Practice, Vol 2009 (2009)
Aim. To evaluate the impact of hepatitis B core antibody (anti-HBc) seropositivity in sustained virological response (SVR) rates in treatment-naïve, chronic hepatitis C (CHC) patients with high pretreatment viral load (>800000 IU/mL). Methods. 185 c
Externí odkaz:
https://doaj.org/article/43065c0cd0fe4374b1357b599e4a8384
Publikováno v:
Expert Opinion on Biological Therapy. 11:301-313
Chronic hepatitis C affects 2.2 - 3% of the world population (130 million - 170 million). Pegylated IFN-α in combination with ribavirin, the currently approved therapy, leads to viral eradication in about 50% of treated patients, nevertheless it is
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::62d2c4a1f4929d76e37806b5c8426ec1
https://doi.org/10.1517/14712598.2011.552906
https://doi.org/10.1517/14712598.2011.552906
Autor:
Massimo Colombo, Elena Vezali
Publikováno v:
Gastroenterology. 139:2209-2212
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3b0518c79575493709551a0495c0b8f8
https://doi.org/10.1053/j.gastro.2010.10.020
https://doi.org/10.1053/j.gastro.2010.10.020
Publikováno v:
Clinical Therapeutics. 32:2117-2138
Background: Cirrhosis developing during chronic infection with the hepatitis C virus (HCV) poses a risk of anticipated liver-related death, therefore representing a dominant indication to anti-HCV therapy. Objective: This review highlights the effica
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5bdd8347c732aeaf5beeb243a5c926d6
https://doi.org/10.1016/s0149-2918(11)00022-1
https://doi.org/10.1016/s0149-2918(11)00022-1
Autor:
Sotirios Koutsounas, Ioannis S. Elefsiniotis, Constantinos Mihas, E. Paraskevas, George Saroglou, Christos Pavlidis, D. Dimitroulopoulos, Elena Vezali, Theodoros Mariolis-Sapsakos
Publikováno v:
Journal of Viral Hepatitis. 16:738-742
Summary. Data concerning the efficacy of PEG-IFNα2a plus ribavirin treatment in treatment-naive, genotype 4-infected chronic hepatitis C (CHC) patients from Europe are limited. Hence the aim of this study was to investigate the viral kinetics as wel
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::46bb434860ad1b0e9de719ae5f1df25f
https://doi.org/10.1111/j.1365-2893.2009.01134.x
https://doi.org/10.1111/j.1365-2893.2009.01134.x
Autor:
Evangelos Konstantinou, Elena Vezali, Ioannis S. Elefsiniotis, Constantinos Mihas, George Saroglou
Publikováno v:
Journal of Gastroenterology and Hepatology. 24:1024-1029
Background and Aims: Thyroid dysfunction (TD) represents an extrahepatic manifestation of chronic hepatitis C (CHC). Moreover, the currently approved treatment of CHC is often associated with TD. However, it remains debatable if TD is mainly virus- o
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f73b7f722edc84ed980df516fc2b7db5
https://doi.org/10.1111/j.1440-1746.2009.05812.x
https://doi.org/10.1111/j.1440-1746.2009.05812.x
Autor:
George Papatsibas, Antonios Moulakakis, Chrysa Kontou-Kastellanou, Michael Skounakis, Maria Pirounaki, Ioannis S. Elefsiniotis, Konstantinos D. Pantazis, Elena Vezali, Aikaterini Petrocheilou
Publikováno v:
European Journal of Gastroenterology & Hepatology. 18:525-530
To evaluate the diagnostic value of serum procalcitonin levels in patients with acute or chronic liver disease, with or without bacterial infections and to correlate the results with the clinical outcome and the laboratory findings for these patients
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::21a09695c66a4073acc4dcc9b908547c
https://doi.org/10.1097/00042737-200605000-00012
https://doi.org/10.1097/00042737-200605000-00012
Autor:
C Stefanadis, K Dimitriadis, Pavlos Toutouzas, Ioannis Kallikazaros, D Chatzis, Dimitris Antoniadis, Costas Tsioufis, S Lalos, Elena Vezali, Alexandra I. Zervoudaki
Publikováno v:
Journal of Human Hypertension. 19:211-217
The role of serum uric acid (SUA) in the context of adverse cardiovascular events in hypertensive subjects is controversial. Additionally, the relationship between SUA and indices of target organ damage is not well defined in this setting. Towards th
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e2d06714ee9aa16d79dadbdaf72ba431
https://doi.org/10.1038/sj.jhh.1001810
https://doi.org/10.1038/sj.jhh.1001810
Autor:
Antonios Moulakakis, V. Paizis, Maria Pirounaki, Ioannis S. Elefsiniotis, N. Boltsis, Elena Vezali
Publikováno v:
International Journal of Clinical Practice. 61:516-518
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0241f6527996aa367350e395380d837f
https://doi.org/10.1111/j.1742-1241.2006.00840.x
https://doi.org/10.1111/j.1742-1241.2006.00840.x
Autor:
Ioannis Kallikazaros, C. Stefanadis, E. Taxiarchou, Constantinos Tsioufis, Elena Vezali, Kyriakos Dimitriadis, Eleutherios Tsiamis, Carmen Vasiliadou
Publikováno v:
Journal of Human Hypertension. 20:470-472
Heavy coffee consumption in conjunction with smoking is accompanied by increased inflammatory processes and impaired thrombosis/fibrinolysis system in essential hypertensive subjects
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c75fe6f92512091bb4951427a227b2c7
https://doi.org/10.1038/sj.jhh.1002014
https://doi.org/10.1038/sj.jhh.1002014